Intercept Pharmaceuticals
0 sources
Financials
0001558370-23-002693Key Facts
- Located in the administrative territorial entity: New York City[1]
- Country: United States[2], US[3]
- Instance of: public company[4]
- Headquarters location: New York City[5]
- Stock exchange: Nasdaq[6]
- Industry: biotechnology[7], pharmaceutical industry[8]
- Inception: 2002[9], 2002-09-04[10]
- Official website: http://www.interceptpharma.com/[11]
- Legal form: Delaware corporation[12], XTIQ[13]
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 254900JMB8TX5P688V24[14]
-
Registered legal name: Intercept Pharmaceuticals, Inc.[15]
-
Legal jurisdiction: US-DE[16]
-
GLEIF entity category: GENERAL[17]
-
Legal form (ISO 20275 ELF): XTIQ[18]
-
Entity status: ACTIVE[19]
-
LEI registration status: LAPSED[20]
-
Entity created: 2002-09-04[21]
-
LEI first registered: 2021-09-24[22]
-
LEI last updated: 2023-09-24[23]
-
LEI next renewal: 2023-09-24[24]
-
Managing LOU: 5493001KJTIIGC8Y1R12[25]
-
Registration authority: RA000602[26]
-
Authority entity ID: 3565213[27]
-
Conformity flag: NON_CONFORMING[28]